Publikationen 2014

  1. Abdel-Wahab M, Mehilli J, Frerker C, Neumann FJ, Kurz T, Tölg R, Zachow D, Guerra E, Massberg S, Schäfer U, El-Mawardy M, Richardt G; CHOICE investigators. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014 Apr 16;311(15):1503-14. doi: 10.1001/jama.2014.3316. PMID  24682026.
  2. Abdel-Wahab M, Mehilli J, Richardt G. Bioprosthetic valves for transcatheter aortic valve replacement--reply. JAMA. 2014 Aug 27;312(8):845-6. doi: 10.1001/jama.2014.8375.
  3. Arking DE, Pulit SL, Crotti L, van der Harst P, Munroe PB, Koopmann TT, Sotoodehnia N, Rossin EJ, Morley M, Wang X, Johnson AD, Lundby A, Gudbjartsson DF, Noseworthy PA, Eijgelsheim M, Bradford Y, Tarasov KV, Dörr M, Müller-Nurasyid M, Lahtinen AM, Nolte IM, Smith AV, Bis JC, Isaacs A, Newhouse SJ, Evans DS, Post WS, Waggott D, Lyytikäinen LP, Hicks AA, Eisele L, Ellinghaus D, Hayward C, Navarro P, Ulivi S, Tanaka T, Tester DJ, Chatel S, Gustafsson S, Kumari M, Morris RW, Naluai ÅT, Padmanabhan S, Kluttig A, Strohmer B, Panayiotou AG, Torres M, Knoflach M, Hubacek JA, Slowikowski K, Raychaudhuri S, Kumar RD, Harris TB, Launer LJ, Shuldiner AR, Alonso A, Bader JS, Ehret G, Huang H, Kao WH, Strait JB, Macfarlane PW, Brown M, Caulfield MJ, Samani NJ, Kronenberg F, Willeit J; CARe Consortium; COGENT Consortium, Smith JG, Greiser KH, Meyer Zu Schwabedissen H, Werdan K, Carella M, Zelante L, Heckbert SR, Psaty BM, Rotter JI, Kolcic I, Polašek O, Wright AF, Griffin M, Daly MJ; DCCT/EDIC, Arnar DO, Hólm H, Thorsteinsdottir U; eMERGE Consortium, Denny JC, Roden DM, Zuvich RL, Emilsson V, Plump AS, Larson MG, O'Donnell CJ, Yin X, Bobbo M, D'Adamo AP, Iorio A, Sinagra G, Carracedo A, Cummings SR, Nalls MA, Jula A, Kontula KK, Marjamaa A, Oikarinen  L, Perola M, Porthan K, Erbel R, Hoffmann P, Jöckel KH, Kälsch H, Nöthen MM; HRGEN Consortium, den Hoed M, Loos RJ, Thelle DS, Gieger C, Meitinger T, Perz S,  Peters A, Prucha H, Sinner MF, Waldenberger M, de Boer RA, Franke L, van der Vleuten PA, Beckmann BM, Martens E, Bardai A, Hofman N, Wilde AA, Behr ER, Dalageorgou C, Giudicessi JR, Medeiros-Domingo A, Barc J, Kyndt F, Probst V, Ghidoni A, Insolia R, Hamilton RM, Scherer SW, Brandimarto J, Margulies K,Moravec CE, del Greco M F, Fuchsberger C, O'Connell JR, Lee WK, Watt GC, Campbell H, Wild SH, El Mokhtari NE, Frey N, Asselbergs FW, Mateo Leach I, Navis G, van den Berg MP, van Veldhuisen DJ, Kellis M, Krijthe BP, Franco OH, Hofman A, Kors JA, Uitterlinden AG, Witteman JC, Kedenko L, Lamina C, Oostra BA, Abecasis GR, Lakatta EG, Mulas A, Orrú M, Schlessinger D, Uda M, Markus MR, Völker U, Snieder  H, Spector TD, Ärnlöv J, Lind L, Sundström J, Syvänen AC, Kivimaki M, Kähönen M,  Mononen N, Raitakari OT, Viikari JS, Adamkova V, Kiechl S, Brion M, Nicolaides AN, Paulweber B, Haerting J, Dominiczak AF, Nyberg F, Whincup PH, Hingorani AD, Schott JJ, Bezzina CR, Ingelsson E, Ferrucci L, Gasparini P, Wilson JF, Rudan I,  Franke A, Mühleisen TW, Pramstaller PP, Lehtimäki TJ, Paterson AD, Parsa A, Liu Y, van Duijn CM, Siscovick DS, Gudnason V, Jamshidi Y, Salomaa V, Felix SB, Sanna S, Ritchie MD, Stricker BH, Stefansson K, Boyer LA, Cappola TP, Olsen JV, Lage K, Schwartz PJ, Kääb S, Chakravarti A, Ackerman MJ, Pfeufer A, de Bakker PI, Newton-Cheh C. Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. Nat Genet. 2014 Aug;46(8):826-36. doi: 10.1038/ng.3014. Epub 2014 Jun 22.
  4. Arsanjani R, Berman DS, Gransar H, Cheng VY, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, Callister TQ, Chang HJ, Cademartiri F, Chinnaiyan KM, Chow BJ, DeLago A, Hadamitzky M, Hausleiter J, Kaufmann P, LaBounty TM, Leipsic J, Raff G, Shaw LJ, Villines TC, Cury RC, Feuchtner G, Kim YJ, Min JK; CONFIRM Investigators. Left ventricular function and volume with coronary CT angiography improves risk stratification and identification of patients at risk for incident mortality: results from 7758 patients in the prospective multinational CONFIRM observational cohort study. Radiology. 2014 Oct;273(1):70-7. doi: 10.1148/radiol.14122816. Epub 2014 Jul 4.
  5. Bamberg F, Marcus RP, Becker A, Hildebrandt K, Bauner K, Schwarz F, Greif M, von Ziegler F, Bischoff B, Becker HC, Johnson TR, Reiser MF, Nikolaou K, Theisen D. Dynamic myocardial CT perfusion imaging for evaluation of myocardial ischemia as determined by MR imaging. JACC Cardiovasc Imaging. 2014 Mar;7(3):267-77. doi: 10.1016/j.jcmg.2013.06.008. Epub 2014 Feb 13.
  6. Beckmann B-M, Kääb S. Genetische Untersuchungen bei arrhythmogenen Erkrankungen: Was ist heute möglich und indiziert? HERZMEDIZIN. Heft 4, Juli 2014.
  7. Beckmann B-M, Kääb S. Genetische Ursachen von Herzrhythmusstörungen: Die Familiengeschichte ist das Fundament. HERZ HEUTE, 03/2014
  8. Boekstegers P, Hausleiter J, Baldus S, von Bardeleben RS, Beucher H, Butter C, Franzen O, Hoffmann R, Ince H, Kuck KH, Rudolph V, Schäfer U, Schillinger W, Wunderlich N; Germany Society of Cardiology Working Group on Interventional Cardiology Focus Group on Interventional Mitral Valve Therapy. Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol. 2014 Feb;103(2):85-96. Review.
  9. Brandt M, Schönfelder T, Schwenk M, Becker C, Jäckel S, Reinhardt C, Stark K, Massberg S, Münzel T, von Brühl ML, Wenzel P. Deep vein thrombus formation induced by flow reduction in mice is determined by venous side branches. Clin Hemorheol Microcirc. 2014;56(2):145-52. doi: 10.3233/CH-131680.
  10. Braun D, Lesevic H, Orban M, Michalk F, Barthel P, Hoppe K, Sonne C, Pache J, Mehilli J, Kastrati A, Hausleiter J, Massberg S. Percutaneous edge-to-edge repair of the mitral valve in patients with degenerative versus functional mitral regurgitation. Catheter Cardiovasc Interv. 2014 Jul 1;84(1):137-46. doi: 10.1002/ccd.25331. Epub 2014 Jan 6. IF: 2,396.
  11. Braun D, Orban M, Tittus J, Schramm R, Hagl C, Hausleiter J. Percutaneous edge-to-edge repair of the mitral valve after heart transplantation. Exp Clin Cardiol Vol 20 Issue 10 pages 5933-5942/2014. IF 0,758.
  12. Brenner C, Kränkel N, Kühlenthal S, Israel L, Remm F, Fischer C, Herbach N, Speer T, Grabmaier U, Laskowski A, Gross L, Theiss H, Wanke R, Landmesser U, Franz WM. Short-term inhibition of DPP-4 enhances endothelial regeneration after acute arterial injury via enhanced recruitment of circulating progenitor cells. Int J Cardiol. 2014 Nov 15;177(1):266-75. doi: 10.1016/j.ijcard.2014.09.016. Epub 2014 Sep 22.
  13. Brilakis ES, Lee M, Mehilli J, Marmagkiolis K, Rodes-Cabau J, Sachdeva R, Kotsia A, Christopoulos G, Rangan BV, Mohammed A, Banerjee S. Saphenous vein graft interventions. Curr Treat Options Cardiovasc Med. 2014 May;16(5):301.
  14. Burridge PW, Matsa E, Shukla P, Lin ZC, Churko JM, Ebert AD, Lan F, Diecke S, Huber B, Mordwinkin NM, Plews JR, Abilez OJ, Cui B, Gold JD, Wu JC. Chemically defined generation of human cardiomyocytes. Nat Methods. 2014 Jun 15.
  15. Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine  clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention. 2014 Jul 18. pii: 20140707-06. doi: 10.4244/EIJY14M07_11. [Epub ahead of print]
  16. Casati D, Stampalija T, Rizas K, Ferrazzi E, Mastroianni C, Rosti E, Quadrifoglio M, Bauer A. Assessment of coupling between trans-abdominally acquired fetal ECG and uterine activity by bivariate phase-rectified signal averaging analysis. PLoS One. 2014 Apr 23;9(4):e94557. doi: 10.1371/journal.pone.0094557. eCollection 2014. IF 3.534.
  17. Chen Y, Wakili R, Xiao J, Wu CT, Luo X, Clauss S, Dawson K, Qi X, Naud P, Shi YF, Tardif JC, Kääb S, Dobrev D, Nattel S. Detailed characterization of microRNA changes in a canine heart failure model: Relationship to arrhythmogenic structural remodeling. J Mol Cell Cardiol. 2014 Oct 12;77C:113-124.
  18. Cho I, Chang HJ, O Hartaigh B, Shin S, Sung JM, Lin FY, Achenbach S, Heo R, Berman DS, Budoff MJ, Callister TQ, Al-Mallah MH, Cademartiri F, Chinnaiyan K, Chow BJ, Dunning AM, DeLago A, Villines TC, Hadamitzky M, Hausleiter J, Leipsic J, Shaw LJ, Kaufmann PA, Cury RC, Feuchtner G, Kim YJ, Maffei E, Raff G, Pontone G, Andreini D, Min JK. Incremental prognostic utility of coronary CT angiography for asymptomatic patients based upon extent and severity of coronary artery calcium: results from the COronary CT Angiography EvaluatioN For Clinical Outcomes InteRnational Multicenter (CONFIRM) Study. Eur Heart J. 2014 Sep 8. pii: ehu358.
  19. Dietzel S, Pircher J, Nekolla AK, Gull M, Brändli AW, Pohl U, Rehberg M.
    Label-free determination of hemodynamic parameters in the microcirculaton with third harmonic generation microscopy. PLoS One. 2014 Jun 16;9(6):e99615. doi: 10.1371/journal.pone.0099615. eCollection 2014.
  20. Ebert AD, Kodo K, Liang P, Wu H, Huber BC, Riegler J, Churko J, Lee J, de Almeida P, Lan F, Diecke S, Burridge PW, Gold JD, Mochly-Rosen D, Wu JC. Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system. Sci Transl Med. 2014 Sep 24;6(255).
  21. Einstein AJ, Berman DS, Min JK, Hendel RC, Gerber TC, Carr JJ, Cerqueira MD, Cullom SJ, DeKemp R, Dickert NW, Dorbala S, Fazel R, Garcia EV, Gibbons RJ, Halliburton SS, Hausleiter J, Heller GV, Jerome S, Lesser JR, Raff GL, Tilkemeier P, Williams KA, Shaw LJ. Patient-centered imaging: shared decision making for cardiac imaging procedures with exposure to ionizing radiation. J Am Coll Cardiol. 2014 Apr 22;63(15):1480-9. doi: 10.1016/j.jacc.2013.10.092. Epub 2014 Feb 13. Review.
  22. Estner HL, Chen J, Potpara T, Proclemer A, Todd D, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Personnel, equipment, and facilities for electrophysiological and catheter ablation procedures in Europe: results of the European Heart Rhythm Association Survey. Europace. 2014 Jul;16(7):1078-82. IF 3.05.
  23. Fichtner S, Kääb S. [Ventricular tachycardia: Treatment and prognostic significance]. Herzschrittmacherther Elektrophysiol. 2013 Dec;24(4):217-22. doi: 10.1007/s00399-013-0296-0. German. Review. Kein IF.
  24. Fiedler KA, Mehilli J, Kufner S, Schlichting A, Ibrahim T, Sibbing D, Ott I, Schunkert H, Laugwitz KL, Kastrati A, Schulz S. Randomised, double-blind trial on the value of tapered discontinuation of clopidogrel maintenance therapy after drug-eluting stent implantation. Intracoronary Stenting and Antithrombotic Regimen: CAUTION in Discontinuing Clopidogrel Therapy--ISAR-CAUTION. Thromb Haemost. 2014 Jun;111(6):1041-9. doi: 10.1160/TH13-11-0900. Epub 2014 Mar 13.
  25. Fiedler KA, Byrne RA, Schulz S, Sibbing D, Mehilli J, Ibrahim T, Maeng M, Laugwitz KL, Kastrati A, Sarafoff N. Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oral anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) study. Am Heart J. 2014 Apr;167(4):459-465.e1. doi: 10.1016/j.ahj.2014.01.005. Epub 2014 Jan 14. Review. IF 4.555.
  26. Geddings J, Aleman MM, Wolberg A, von Brühl ML, Massberg S, Mackman N. Strengths and weaknesses of a new mouse model of thrombosis induced by inferior vena cava stenosis: communication from the SSC of the ISTH. J Thromb Haemost. 2014 Apr;12(4):571-3. doi: 10.1111/jth.12510.
  27. Gorenek B, Blomström Lundqvist C, Brugada Terradellas J, Camm AJ, Hindricks G, Huber K, Kirchhof P, Kuck KH, Kudaiberdieva G, Lin T, Raviele A, Santini M, Tilz  RR, Valgimigli M, Vos MA, Vrints C, Zeymer U, Lip GY, Potpara T, Fauchier L, Sticherling C, Roffi M, Widimsky P, Mehilli J, Lettino M, Schiele F, Sinnaeve P,  Boriani G, Lane D, Savelieva I. Cardiac arrhythmias in acute coronary syndromes:  position paper from the joint EHRA, ACCA, and EAPCI task force. Europace. 2014 Nov;16(11):1655-73. doi: 10.1093/europace/euu208. Epub 2014 Aug 29.
  28. *Grabmaier U, *Theiss HD, Keithahn A, Kreiner J, Brenner C, Huber B, von der Helm C, Gross L, Klingel K, Franz WM, Brunner S. The role of 1.5 tesla MRI and anesthetic regimen concerning cardiac analysis in mice with cardiomyopathy. PLoS One. 2014 Apr 18;9(4):e94615. doi: 10.1371/journal.pone.0094615. eCollection 2014. IF 3.534.
  29. Grabmaier U, Brandl L, Kreiner J, Negele T, Huber BC, Rimmbach C, David R, Brunner S. Increased Numbers Of Bone Marrow-Derived Cells In Parathyroid Adenoma. Eur J Clin Invest. 2014 Sep;44(9):833-9. IF 2,834.
  30. Grazia Bongiorni M, Dagres N, Estner H, Pison L, Todd D, Blomstrom-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Management of malfunctioning and recalled pacemaker and defibrillator leads: results of the European Heart Rhythm Association survey. Europace. 2014 Nov;16(11):1674-8.
  31. Greif M*, Lange P*, Näbauer M, Schwarz F, Becker C, Schmitz C, Pohl T, D'Anastasi M, Boekstegers P, Massberg S, Kupatt C. Transcutaneous aortic valve replacement with the Edwards SAPIEN XT and Medtronic CoreValve prosthesis under fluoroscopic guidance and local anaesthesia only. Heart. 2014 May;100(9):691-5. doi: 10.1136/heartjnl-2013-304918. Epub 2014 Jan 23. IF 6.023.
  32. Gründler K, Angstwurm M, Hilge R, Baumann P, Annecke T, Crispin A, Sohn HY, Massberg S, Kraemer BF. Platelet mitochondrial membrane depolarization reflects disease severity in patients with sepsis and correlates with clinical outcome. Crit Care. 2014 Feb 12;18(1):R31. IF 5.035.
  33. *Guenther S, *Theiss HD, Fischer M, Sattler S, Peterss S, Born F, Pichlmaier M, Massberg S, Hagl C, Khaladj N. Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team. Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):283-91. IF 1.109.
  34. Hildemann SK, Schulz C, Fraccarollo D, Schöpp C, Flierl U, Wissel K, Pelisek J, Massberg S, Bauersachs J, Schäfer A. Fractalkine promotes platelet activation and vascular dysfunction in congestive heart failure. Thromb Haemost. 2014 Apr 1;111(4):725-35. doi: 10.1160/TH13-08-0640. Epub 2013 Dec 12. IF 5.76.
  35. Huber BC, Grabmaier U, Brunner S. Impact of parathyroid hormone on bone marrow-derived stem cell mobilization and migration. World J Stem Cells. 2014 Nov 26;6(5):637-43. Review. No IF.
  36. Hulten E, Villines TC, Cheezum MK, Berman DS, Dunning A, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng VY, Chinnaiyan K, Chow BJ, Cury RC, Delago A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann PA, Kim YJ, Leipsic J, Lin FY, Maffei E, Plank F, Raff GL, Shaw LJ, Min JK; CONFIRM Investigators. Calcium score, coronary artery disease extent and severity, and clinical outcomes among low Framingham risk patients with low vs high lifetime risk: results from the CONFIRM registry. J Nucl Cardiol. 2014 Feb;21(1):29-37; quiz 38-9. doi: 10.1007/s12350-013-9819-7. Epub 2014 Jan 3.
  37. Jochheim D, Schneider VS, Schwarz F, Kupatt C, Lange P, Reiser M, Massberg S, Gutiérrez-Chico JL, Mehilli J, Becker HC. Contrast-induced acute kidney injury after computed tomography prior to transcatheter aortic valve implantation. Clin Radiol. 2014 Oct;69(10):1034-8. doi: 10.1016/j.crad.2014.05.106. Epub 2014 Jul 10. IF 1.663.
  38. Kalra PR, García-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG; CLARIFY Investigators. Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients. PLoS One. 2014 Jul 22;9(7):e102335. doi: 10.1371/journal.pone.0102335. eCollection 2014.
  39. Lambiase PD, Barr C, Theuns DA, Knops R, Neuzil P, Johansen JB, Hood M, Pedersen S, Kääb S, Murgatroyd F, Reeve HL, Carter N, Boersma L; EFFORTLESS Investigators. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry. Eur Heart J. 2014 Jul 1;35(25):1657-65.
  40. Lange P, Greif M, Vogel A, Thaumann A, Helbig S, Schwarz F, Schmitz C, Becker C, D'Anastasi M, Boekstegers P, Pohl T, Laubender RP, Steinbeck G, Kupatt C. Reduction of pacemaker implantation rates after CoreValve® implantation by moderate predilatation. EuroIntervention. 2014 Feb;9(10):1151-7. IF 3.758.
  41. Langhans B, Hausleiter J, Bamberg F. Independent prognostic value of MRI beyond existing methods of determining cardiovascular risk - is there a role? Expert Rev Cardiovasc Ther. 2014 Jan;12(1):13-6. doi: 10.1586/14779072.2014.865518. Epub 2013 Dec 2. Review.
  42. Larsen TB, Potpara T, Dagres N, Pison L, Estner H, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Stroke and bleeding risk evaluation in atrial fibrillation: results of the European Heart Rhythm Association survey. Europace. 2014 May;16(5):698-702. doi: 10.1093/europace/euu089.
  43. Lehner S, Todica A, Vanchev Y, Uebleis C, Wang H, Herrler T, Wängler C, Cumming P, Böning G, Franz WM, Bartenstein P, Hacker M, Brunner S. In Vivo Monitoring of Parathyroid Hormone Treatment after Myocardial Infarction in Mice with [68Ga]Annexin A5 and [18F]Fluorodeoxyglucose Positron Emission Tomography. Mol Imaging. 2014 Sep 1;13(0):1-8. IF 2.191.
  44. Lehner S, Sussebach C, Todica A, Uebleis C, Brunner S, Bartenstein P, Van Kriekinge SD, Germano G, Hacker M. Influence of SPECT attenuation correction on the quantification of hibernating myocardium as derived from combined myocardial perfusion SPECT and 18F-FDG PET. J Nucl Cardiol 2014 Jun;21(3):578-87.
  45. Lehner S, Uebleis C, Schüßler F, Haug A, Kääb S, Bartenstein P, Van Kriekinge SD, Germano G, Estner H, Hacker M. The amount of viable and dyssynchronous myocardium is associated with response to cardiac resynchronization therapy: initial clinical results using multiparametric ECG-gated [18F]FDG PET. Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1876-83.
  46. Leipsic J, Taylor CM, Gransar H, Shaw LJ, Ahmadi A, Thompson A, Humphries K, Berman DS, Hausleiter J, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Chow BJ, Cury RC, Delago AJ, Dunning AL, Feuchtner GM, Hadamitzky M, Kaufmann PA, Lin FY, Chinnaiyan KM, Maffei E, Raff GL, Villines TC, Gomez MJ, Min JK. Sex-based prognostic implications of nonobstructive coronary artery disease: results from the international multicenter CONFIRM study. Radiology. 2014 Nov;273(2):393-400. doi: 10.1148/radiol.14140269. Epub 2014 Jul 15.
  47. Lemaitre RN, Johnson CO, Hesselson S, Sotoodehnia N, McKnight B, Sitlani CM, Rea TD, King IB, Kwok PY, Mak A, Li G, Brody J, Larson E, Mozaffarian D, Psaty BM, Huertas-Vazquez A, Tardif JC, Albert CM, Lyytikäinen LP, Arking DE, Kääb S, Huikuri HV, Krijthe BP, Eijgelsheim M, Wang YA, Reinier K, Lehtimäki T, Pulit SL, Brugada R, Müller-Nurasyid M, Newton-Cheh CH, Karhunen PJ, Stricker BH, Goyette P, Rotter JI, Chugh SS, Chakravarti A, Jouven X, Siscovick DS. Common variation in fatty acid metabolic genes and risk of incident sudden cardiac arrest. Heart Rhythm. 2014 Mar;11(3):471-7. doi: 10.1016/j.hrthm.2014.01.008. Epub 2014 Jan 10. Erratum in: Heart Rhythm. 2014 Aug;11(8):1496.
  48. Lubitz SA, Lunetta KL, Lin H, Arking DE, Trompet S, Li G, Krijthe BP, Chasman DI, Barnard J, Kleber ME, Dörr M, Ozaki K, Smith AV, Müller-Nurasyid M, Walter S, Agarwal SK, Bis JC, Brody JA, Chen LY, Everett BM, Ford I, Franco OH, Harris TB, Hofman A, Kääb S, Mahida S, Kathiresan S, Kubo M, Launer LJ, Macfarlane PW, Magnani JW, McKnight B, McManus DD, Peters A, Psaty BM, Rose LM, Rotter JI, Silbernagel G, Smith JD, Sotoodehnia N, Stott DJ, Taylor KD, Tomaschitz A, Tsunoda T, Uitterlinden AG, Van Wagoner DR, Völker U, Völzke H, Murabito JM, Sinner MF, Gudnason V, Felix SB, März W, Chung M, Albert CM, Stricker BH, Tanaka T, Heckbert SR, Jukema JW, Alonso A, Benjamin EJ, Ellinor PT. Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. J Am Coll Cardiol. 2014 Apr 1;63(12):1200-10.
  49. Makita N, Yagihara N, Crotti L, Johnson CN, Beckmann BM, Roh MS, Shigemizu D, Lichtner P, Ishikawa T, Aiba T, Homfray T, Behr ER, Klug D, Denjoy I, Mastantuono E, Theisen D, Tsunoda T, Satake W, Toda T, Nakagawa H, Tsuji Y, Tsuchiya T, Yamamoto H, Miyamoto Y, Endo N, Kimura A, Ozaki K, Motomura H, Suda K, Tanaka T,  Schwartz PJ, Meitinger T, Kääb S, Guicheney P, Shimizu W, Bhuiyan ZA, Watanabe H, Chazin WJ, George AL Jr. Novel calmodulin mutations associated with congenital arrhythmia susceptibility. Circ Cardiovasc Genet. 2014 Aug;7(4):466-74. doi: 10.1161/CIRCGENETICS.113.000459. Epub 2014 Jun 10.
  50. Martens E, Sinner MF, Siebermair J, Raufhake C, Beckmann BM, Veith S, Düvel D, Steinbeck G, Kääb S. Incidence of sudden cardiac death in Germany: results from an emergency medical service registry in Lower Saxony. Europace. 2014 Dec;16(12):1752-8. doi: 10.1093/europace/euu153. Epub 2014 Jul 24. IF 3.05.
  51. Marwan M, Hausleiter J, Abbara S, Hoffmann U, Becker C, Ovrehus K, Ropers D, Bathina R, Berman D, Anders K, Uder M, Meave A, Alexánderson E, Achenbach S. Multicenter Evaluation Of Coronary Dual-Source CT angiography in patients with intermediate Risk of Coronary Artery Stenoses (MEDIC): study design and rationale. J Cardiovasc Comput Tomogr. 2014 May-Jun;8(3):183-8. doi: 10.1016/j.jcct.2014.04.006. Epub 2014 Apr 30.
  52. Mayer K, Bernlochner I, Braun S, Schulz S, Orban M, Morath T, Cala L, Hoppmann P, Schunkert H, Laugwitz KL, Kastrati A, Sibbing D. Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI registry. J Am Coll Cardiol. 2014 Sep 2;64(9):863-71. IF 15.343.
  53. Mayer K, Schulz S, Bernlochner I, Morath T, Braun S, Hausleiter J, Massberg S, Schunkert H, Laugwitz KL, Kastrati A, Sibbing D. A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry. Thromb Haemost. 2014 Aug;112(2):342-51. doi: 10.1160/TH13-10-0874. Epub 2014 Apr 10. IF 5.760.
  54. Mayer K, Orban M, Bernlochner I, Braun S, Schulz S, Gross L, Hadamitzky M, Schunkert H, Laugwitz KL, Massberg S, Kastrati A, Sibbing D. Predictors of antiplatelet response to prasugrel during maintenance treatment. Platelets. 2014  Jan 16. [Epub ahead of print]. IF 2.627.
  55. Mehilli J, Massberg S. Revisiting the BIOSCIENCE of drug-eluting stent technology. Lancet. 2014 Dec 13;384(9960):2086-8. doi: 10.1016/S0140-6736(14)61415-X. Epub 2014 Sep 1. Editorial. IF 39,207.
  56. Muehling OM, Wakili R, Greif M, von Ziegler F, Morhard D, Brueckmann H, Becker A. Immediate and 12 months follow up of function and lead integrity after cranial MRI in 356 patients with conventional cardiac pacemakers. J Cardiovasc Magn Reson. 2014 Jun 5;16:39.
  57. Nakazato R, Arsanjani R, Achenbach S, Gransar H, Cheng VY, Dunning A, Lin FY, Al-Mallah M, Budoff MJ, Callister TQ, Chang HJ, Cademartiri F, Chinnaiyan K, Chow BJ, Delago A, Hadamitzky M, Hausleiter J, Kaufmann P, Raff G, Shaw LJ, Villines T, Cury RC, Feuchtner G, Kim YJ, Leipsic J, Berman DS, Min JK. Age-related risk of major adverse cardiac event risk and coronary artery disease extent and severity by coronary CT angiography: results from 15 187 patients from the International Multisite CONFIRM Study. Eur Heart J Cardiovasc Imaging. 2014 May;15(5):586-94. doi: 10.1093/ehjci/jet132. Erratum in: Eur Heart J Cardiovasc Imaging. 2014 Sep;15(9):955.
  58. Neuberger HR, Tilz RR, Bonnemeier H, Deneke T, Estner HL, Kriatselis C, Kuniss M, Luik A, Sommer P, Steven D, von Bary C, Voss F, Eckardt L. A survey of German centres performing invasive electrophysiology: structure, procedures, and training positions. Europace. 2013 Dec;15(12):1741-6.
  59. Orban M*, Braun D*, Sonne C, Orban M, Thaler R, Grebmer C, Lesevic H, Schömig A, Mehilli J, Massberg S, Hausleiter J. Dangerous liaison: successful percutaneous edge-to-edge mitral valve repair in patients with end-stage systolic heart failure can cause left ventricular thrombus formation. EuroIntervention. 2014 Jun;10(2):253-9. doi: 10.4244/EIJV10I2A41. IF: 3.758.
  60. Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, Schulz S, Hoppmann P, Hausleiter J, Tiroch K, Mehilli J, Schunkert H, Massberg S, Laugwitz  KL, Sibbing D*, Kastrati A*. Prasugrelvs clopidogrel in cardiogenic shock patients  undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry. Thromb Haemost. 2014 Dec 1;112(6):1190-7. doi: 10.1160/TH14-06-0489. Epub 2014 Aug 28. IF 5.76.
  61. Pfeiler S, Massberg S, Engelmann B. Biological basis and pathological relevance of microvascular thrombosis. Thromb Res. 2014 May;133 Suppl 1:S35-7. doi: 10.1016/j.thromres.2014.03.016. PMID: 24759139.
  62. Pircher J, Czermak T, Merkle M, Mannell H, Krötz F, Ribeiro A, Vielhauer V, Nadjiri J, Gaitzsch E, Niemeyer M, Porubsky S, Gröne HJ, Wörnle M.
    Hepatitis C Virus Induced Endothelial Inflammatory Response Depends on the Functional Expression of TNFα Receptor Subtype 2. PLoS One. 2014 Nov 24;9(11):e113351. doi: 10.1371/journal.pone.0113351. eCollection 2014. IF 3,534.
  63. Potpara TS, Lip GY, Dagres N, Estner HL, Larsen TB, Blomström-Lundqvist C; Conducted by the Scientific Initiatives Committee, European Heart Rhythm Association. Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey. Europace. 2014 Feb;16(2):293-8. doi: 10.1093/europace/euu008.
  64. Proclemer A, Grazia Bongiorni M, Etsner H, Todd D, Sciaraffia E, Blomström-Lundqvist C; Scientific Initiatives Committee, European Heart Rhythm Association. Current implantable cardioverter-defibrillator programming in Europe: the results of the European Heart Rhythm Association survey. Europace. 2014 Jun;16(6):935-8.
  65. Rizas KD, Nieminen T, Barthel P, Zürn CS, Kähönen M, Viik J, Lehtimäki T, Nikus K, Eick C, Greiner TO, Wendel HP, Seizer P, Schreieck J, Gawaz M, Schmidt G, Bauer A. Sympathetic activity-associated periodic repolarization dynamics predict mortality following myocardial infarction. J Clin Invest. 2014 Apr 1;124(4):1770-80. doi: 10.1172/JCI70085. Epub 2014 Mar 18. IF 13,765.
  66. Sanchez-Freire V, Lee AS, Hu S, Abilez OJ, Liang P, Lan F, Huber BC, Ong SG, Hong WX, Huang M, Wu JC. Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells. J Am Coll Cardiol. 2014 Aug 5;64(5):436-48.
  67. Sattler S, Khaladj N, Zaruba MM, Fischer M, Hausleiter J, Mehilli J, Kääb S, Hagl C, Massberg S, Theiss HD. Extracorporal life support (ECLS) in acute ischaemic cardiogenic shock. Int J Clin Pract. 2014 Apr;68(4):529-31. doi: 10.1111/ijcp.12380. IF 2.538.
  68. Schuhmann CG, Hacker M, Jung P, Krötz F, Sohn HY. Myeloperoxidase is not useful for detecting stress inducible myocardial ischemia but may be indicative of the severity of coronary artery disease. Korean Circulation Journal. 44(1):10-5 2014 Jan. Epub 2014 Jan 14. No IF.
  69. Schulman-Marcus J, Hartaigh BO, Giambrone AE, Gransar H, Valenti V, Berman DS, Budoff MJ, Achenbach S, Al-Mallah M, Andreini D, Cademartiri F, Callister TQ, Chang HJ, Chinnaiyan K, Chow BJ, Cury R, Delago A, Hadamitzky M, Hausleiter J, Feuchtner G, Kim YJ, Kaufmann PA, Leipsic J, Lin FY, Maffei E, Pontone G, Raff G, Shaw LJ, Villines TC, Dunning A, Min JK. Effects of cardiac medications for patients with obstructive coronary artery disease by coronary computed tomographic angiography: Results from the multicenter CONFIRM registry. Atherosclerosis. 2014 Nov 14;238(1):119-125.
  70. Schulz C, Massberg S. Atherosclerosis--multiple pathways to lesional macrophages. Sci Transl Med. 2014 Jun 4;6(239):239ps2. doi: 10.1126/scitranslmed.3008922. Review. IF 14.41
  71. Schulz S, Richardt G, Laugwitz KL, Morath T, Neudecker J, Hoppmann P, Mehran R, Gershlick AH, Tölg R, Anette Fiedler K, Abdel-Wahab M, Kufner S, Schneider S,  Schunkert H, Ibrahim T, Mehilli J, Kastrati A; Bavarian Reperfusion Alternatives  Evaluation (BRAVE) 4 Investigators. Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction. Eur Heart J. 2014 Sep 7;35(34):2285-94. doi: 10.1093/eurheartj/ehu182. Epub 2014 May.
  72. Schulz S, Richardt G, Laugwitz KL, Mehran R, Gershlick AH, Morath T, Mayer K, Neudecker J, Tölg R, Ibrahim T, Hauschke D, Braun D, Schunkert H, Kastrati A, Mehilli J; Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 Investigators. Comparison of prasugrel and bivalirudin vs clopidogrel and heparin in patients with ST-segment elevation myocardial infarction: Design and rationale of the Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 trial. Clin Cardiol. 2014 May;37(5):270-6. doi: 10.1002/clc.22268. Epub 2014 Mar 14. IF: 2.225.
  73. Schulz-Schüpke S, Helde S, Gewalt S, Ibrahim T, Linhardt M, Haas K, Hoppe K, Böttiger C, Groha P, Bradaric C, Schmidt R, Bott-Flügel L, Ott I, Goedel J, Byrne RA, Schneider S, Burgdorf C, Morath T, Kufner S, Joner M, Cassese S, Hoppmann P, Hengstenberg C, Pache J, Fusaro M, Massberg S, Mehilli J, Schunkert H, Laugwitz KL, Kastrati A. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial. Instrumental Sealing of Arterial Puncture Site—CLOSURE Device vs Manual Compression (ISAR-CLOSURE) Trial Investigators. JAMA. 2014 Nov 19;312(19):1981-7. doi: 10.1001/jama.2014.15305.
  74. Schwarz F, Lange P, Zinsser D, Greif M, Boekstegers P, Schmitz C, Reiser MF, Kupatt C, Becker HC. CT-angiography-based evaluation of the aortic annulus for prosthesis sizing in transcatheter aortic valve implantation (TAVI)-predictive value and optimal thresholds for major anatomic parameters. PLoS One. 2014 Aug 1;9(8):e103481. doi: 10.1371/journal.pone.0103481. eCollection 2014.
  75. Semmler V, Fichtner S, Lennerz C, Kolb C. Very late perforation of an implantable cardioverter defibrillator lead: a case report. Br J Gen Pract. 2014 Feb;64(619):107-8. doi: 10.3399/bjgp14X677329.
  76. Shah S, Bellam N, Leipsic J, Berman DS, Quyyumi A, Hausleiter J, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Chow BJ, Cury RC, Delago AJ, Dunning AL, Feuchtner GM, Hadamitzky M, Karlsberg RP, Kaufmann PA, Lin FY, Chinnaiyan KM, Maffei E, Raff GL, Villines TC, Gomez MJ, Min JK, Shaw LJ; CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry) Investigators. Prognostic significance of calcified plaque among symptomatic patients with nonobstructive coronary artery disease. J Nucl Cardiol. 2014 Jun;21(3):453-66. doi: 10.1007/s12350-014-9865-9. Epub 2014 Mar 29.
  77. Shi DS, Smith MC, Campbell RA, Zimmerman PW, Franks ZB, Kraemer BF, Machlus KR, Ling J, Kamba P, Schwertz H, Rowley JW, Miles RR, Liu ZJ, Sola-Visner M, Italiano JE Jr, Christensen H, Kahr WH, Li DY, Weyrich AS. Proteasome function is required for platelet production. J Clin Invest. 2014 Sep 2;124(9):3757-66.
  78. Sibbing D, Schulz C. Platelet CCL5 links acute coronary syndrome and vascular inflammation. Thromb Haemost. 2014 Dec 1;112(6):1079. doi: 10.1160/TH14-11-0910. Epub 2014 Nov 13. Editorial. IF 5.76.
  79. Sibbing D, Massberg S. Dual antiplatelet treatment after stenting: is longer better? Lancet. 2014 Nov 1;384(9954):1553-5. doi: 10.1016/S0140-6736(14)60768-6.  Epub 2014 Jul 15. Editorial. IF 39,207.
  80. Sibbing D, Massberg S. There's life in the old dog yet: clopidogrel competing with prasugrel and ticagrelor for treatment of ACS patients. Thromb Haemost. 2014Jul 3;112(1):10-1. doi: 10.1160/TH14-03-0216. Epub 2014 May 8. Editorial. IF 5.76.
  81. Sibbing D, Spannagl M. Direct oral anticoagulants and antiplatelet agents. Clinical relevance and options for laboratory testing. Hamostaseologie. 2014 Feb  4;34(1):78-84. doi: 10.5482/HAMO-13-11-0055. Epub 2013 Dec 4. Review. IF 1.589.
  82. Siebermair J, Clauss S, Martens E, Schuessler F, Oversohl N, Haserueck N, Estner HL, Kääb S, Wakili R. Remote monitoring of implantable cardioverter-defibrillators : Problems and implications using a telemonitoring system. Herz. 2014 May 23. IF 0.982.
  83. Sinner MF, Tucker NR, Lunetta KL, Ozaki K, Smith JG, Trompet S, Bis JC, Lin H, Chung MK, Nielsen JB, Lubitz SA, Krijthe BP, Magnani JW, Ye J, Gollob MH, Tsunoda T, Müller-Nurasyid M, Lichtner P, Peters A, Dolmatova E, Kubo M, Smith JD, Psaty BM, Smith NL, Jukema JW, Chasman DI, Albert CM, Ebana Y, Furukawa T, Macfarlane PW, Harris TB, Darbar D, Dörr M, Holst AG, Svendsen JH, Hofman A, Uitterlinden AG, Gudnason V, Isobe M, Malik R, Dichgans M, Rosand J, Van Wagoner DR; METASTROKE Consortium; AFGen Consortium, Benjamin EJ, Milan DJ, Melander O, Heckbert SR, Ford I, Liu Y, Barnard J, Olesen MS, Stricker BH, Tanaka T, Kääb S*, Ellinor PT*. Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation. 2014 Oct 7;130(15):1225-35. doi: 10.1161/CIRCULATIONAHA.114.009892. Epub 2014 Aug 14. IF 14.948.
  84. Sinner MF, Stepas KA, Moser CB, Krijthe BP, Aspelund T, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Vasan RS, Wang TJ, Agarwal SK, McManus DD, Franco OH, Yin X, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb S, Couper D,Harris TB, Astor BC, Ballantyne CM, Hoogeveen RC, Arai AE, Soliman EZ, Ellinor PT, Stricker BH, Gudnason V, Heckbert SR, Pencina MJ, Benjamin EJ, Alonso A.B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies. Europace. 2014 Oct;16(10):1426-33. IF 3.05.
  85. Sonne C, Bott-Flugel L, Hauck S, Hadamitzky M, Lesevic H, Demetz G, Braun D, Wolf P, Hausleiter J, Schömig A, Kolb C. Three-dimensional echocardiographic optimization improves outcome in cardiac resynchronization therapy compared to ECG optimization: a randomized comparison. Pacing Clin Electrophysiol. 2014 Mar;37(3):312-20. doi: 10.1111/pace.12281. IF 1.25.
  86. Speicher T, Siegenthaler B, Bogorad RL, Ruppert R, Petzold T, Padrissa-Altes S, Bachofner M, Anderson DG, Koteliansky V, Fässler R, Werner S. Knockdown and knockout of β1-integrin in hepatocytes impairs liver regeneration through inhibition of growth factor signalling Nat Communication 2014.
  87. Tada T, Kastrati A, Byrne RA, Schuster T, Cuni R, King LA, Cassese S, Joner M, Pache J, Massberg S, Schömig A, Mehilli J. Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography. Int J Cardiovasc Imaging. 2014 Mar;30(3):495-504. doi: 10.1007/s10554-014-0376-1. Epub 2014 Jan 23. PMID: 24452729.  IF 2.322.
  88. Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, Fusaro M, Schneider S, Schulz S, Ibrahim T, Ott I, Massberg S, Laugwitz KL, Kastrati A. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients. JACC Cardiovasc Interv. 2013 Dec;6(12):1267-74.
  89. Tiroch K, Mehilli J, Byrne RA, Schulz S, Massberg S, Laugwitz KL, Vorpahl M, Seyfarth M, Kastrati A; ISAR-LEFT MAIN Study Investigators. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11.
  90. Todica A, Zacherl MJ, Wang H, Böning G, Jansen NL, Wängler C, Bartenstein P, Kreissl MC, Hacker M, Brunner S, Lehner S. In-vivo monitoring of erythropoietin treatment after myocardial infarction in mice with [68Ga]Annexin A5 and [18F]FDG PET. J Nucl Cardiol. 2014 Sep 5.
  91. Wellens HJ, Schwartz PJ, Lindemans FW, Buxton AE, Goldberger JJ, Hohnloser SH, Huikuri HV, Kääb S, La Rovere MT, Malik M, Myerburg RJ, Simoons ML, Swedberg K, Tijssen J, Voors AA, Wilde AA. Risk stratification for sudden cardiac death: current status and challenges for the future. Eur Heart J. 2014 Jul 1;35(25):1642-51.
  92. Xhepa E, Byrne RA, Schulz S, Helde S, Gewalt S, Cassese S, Linhardt M, Ibrahim T, Mehilli J, Hoppe K, Grupp K, Kufner S, Böttiger C, Hoppmann P, Burgdorf C, Fusaro M, Ott I, Schneider S, Hengstenberg C, Schunkert H, Laugwitz KL, Kastrati A; ISAR-CLOSURE investigators. Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trial. EuroIntervention. 2014 Jun;10(2):198-203.
  93. von Ziegler F, Greif M, Tittus J, Schenzle J, Becker C, Becker A. Distribution of coronary calcifications in patients with suspected coronary heart disease. Am Heart J. 2014 Apr;167(4):568-75. doi: 10.1016/j.ahj.2013.12.011. Epub 2014 Jan 3. IF 4.555.
  94. Zuern CS, Rizas KD, Eick C, Vogtt MI, Bigalke B, Gawaz M, Bauer A. Severe autonomic failure as a predictor of mortality in aortic valve stenosis. Int J Cardiol. 2014 Oct 20;176(3):782-7. doi: 10.1016/j.ijcard.2014.07.088. Epub 2014 Aug 2. IF 6.175.
 
 

Campus Großhadern

24h-Notfallnummer
+49 89 4400-75227

Stationäre Aufnahme\
Patientenmanagement

Normalstationen
+49 89 4400-73061

Privatstationen
+49 89 4400-72368


Kardiologische Ambulanz
+49 89 4400-73061

Kardiologische Intensivstation
+49 89 4400-75226

Chest Pain Unit
+49 89 4400-72302

Rhythmologische Hotline
+49 89 4400-73102

Zentrale Notaufnahme
+49 89 4400-73490

Campus Innenstadt

24h-Notfallnummer
+49 89 4400-55001

Stationäre Aufnahme\
Patientenmanagement

Kardiologische Station M2a\
Herzkatheter
+49 89 4400-52316


Kardiologische Ambulanz
+49 89 4400-52305
+49 89 4400-52385

Herzinfarkt_Netzwerk